Coleen Glessner sold $306K of Emergent BioSolutions (EBS)

Executed Oct 7 2025, disclosed Oct 16 2025, 9 days later, against a two-business-day limit.

Value, as filed

$306K

30,608 sh × $10.00

Executed

Oct 7 2025

the trade date, as filed

Disclosed

Oct 16 2025

9 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CG Coleen Glessner EVP, Quality & Ethics, and CPL profile →

Coleen Glessner (EVP, Quality & Ethics, and CPL) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Emergent BioSolutions Inc. (EBS). The largest single filing was $306K of EBS (30,608 sh × $10.00, as filed), executed Oct 7 2025.

The name

EBS Emergent BioSolutions Inc. EBS · Healthcare · 13 filings in 24 months ticker →

Healthcare · Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→